Your browser doesn't support javascript.
loading
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch, Birke; Schiavi, Francesca; Ni, Ying; Welander, Jenny; Patocs, Attila; Ngeow, Joanne; Wellner, Ulrich; Malinoc, Angelica; Taschin, Elisa; Barbon, Giovanni; Lanza, Virginia; Söderkvist, Peter; Stenman, Adam; Larsson, Catharina; Svahn, Fredrika; Chen, Jin-Lian; Marquard, Jessica; Fraenkel, Merav; Walter, Martin A; Peczkowska, Mariola; Prejbisz, Aleksander; Jarzab, Barbara; Hasse-Lazar, Kornelia; Petersenn, Stephan; Moeller, Lars C; Meyer, Almuth; Reisch, Nicole; Trupka, Arnold; Brase, Christoph; Galiano, Matthias; Preuss, Simon F; Kwok, Pingling; Lendvai, Nikoletta; Berisha, Gani; Makay, Özer; Boedeker, Carsten C; Weryha, Georges; Racz, Karoly; Januszewicz, Andrzej; Walz, Martin K; Gimm, Oliver; Opocher, Giuseppe; Eng, Charis; Neumann, Hartmut P H.
Afiliação
  • Bausch B; Department of Medicine II, Freiburg University Medical Center, Albert-Ludwigs University, Freiburg, Germany.
  • Schiavi F; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
  • Ni Y; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Welander J; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
  • Patocs A; Second Department of Medicine, Semmelweis University, Budapest, Hungary.
  • Ngeow J; Molecular Medicine Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary.
  • Wellner U; Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Malinoc A; Department of Surgery, University of Lübeck, Lübeck, Germany.
  • Taschin E; Department of Nephrology and General Medicine, University Medical Center, Albert-Ludwigs University, Freiburg, Germany.
  • Barbon G; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
  • Lanza V; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
  • Söderkvist P; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
  • Stenman A; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
  • Larsson C; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden.
  • Svahn F; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden.
  • Chen JL; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden.
  • Marquard J; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Fraenkel M; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Walter MA; Department of Medicine, Endocrinology, and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Peczkowska M; Institute of Nuclear Medicine, University Hospital, Bern, Switzerland.
  • Prejbisz A; Department of Hypertension, Institute of Cardiology, Warsaw, Poland.
  • Jarzab B; Department of Hypertension, Institute of Cardiology, Warsaw, Poland.
  • Hasse-Lazar K; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Petersenn S; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Moeller LC; Center for Endocrine Tumors, Hamburg, Germany.
  • Meyer A; Department of Endocrinology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
  • Reisch N; Department of Endocrinology, Helios Klinikum, Erfurt, Germany.
  • Trupka A; Department of Endocrinology, Ludwigs-Maximilians University of Munich, Munich, Germany.
  • Brase C; Department of Surgery, City Hospital, Starnberg, Germany.
  • Galiano M; Department of Otorhinolaryngology, University of Erlangen, Erlangen, Germany.
  • Preuss SF; Department of Pediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
  • Kwok P; Department of Otolaryngology, University of Cologne, Cologne, Germany.
  • Lendvai N; Department of Otorhinolaryngology, University of Regensburg, Regensburg, Germany.
  • Berisha G; Molecular Medicine Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary.
  • Makay Ö; Department of Nephrology and General Medicine, University Medical Center, Albert-Ludwigs University, Freiburg, Germany.
  • Boedeker CC; Division of Endocrine Surgery, Department of General Surgery, Ege University, Izmir, Turkey.
  • Weryha G; Department of Otolaryngology, HELIOS Hanseklinikum Stralsund, Stralsund, Germany.
  • Racz K; Department of Endocrinology, University of Nancy, Nancy, France.
  • Januszewicz A; Second Department of Medicine, Semmelweis University, Budapest, Hungary.
  • Walz MK; Department of Hypertension, Institute of Cardiology, Warsaw, Poland.
  • Gimm O; Department of Surgery and Center of Minimally Invasive Surgery, Kliniken Essen-Mitte, Essen, Germany.
  • Opocher G; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
  • Eng C; Department of Surgery, Region Östergötland, Linköping, Sweden.
  • Neumann HPH; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
JAMA Oncol ; 3(9): 1204-1212, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28384794
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Segunda Neoplasia Primária / Neoplasias das Glândulas Suprarrenais / Paraganglioma Extrassuprarrenal / Predisposição Genética para Doença / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Segunda Neoplasia Primária / Neoplasias das Glândulas Suprarrenais / Paraganglioma Extrassuprarrenal / Predisposição Genética para Doença / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2017 Tipo de documento: Article